Literature DB >> 26951255

Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis.

Vahid Ziaee1,2, Arezou Rezaei3, Sara Harsini3,4, Marzieh Maddah2, Samaneh Zoghi4,5, Maryam Sadr6, Mohammad Hassan Moradinejad2, Nima Rezaei7,8,9.   

Abstract

As cytokines, including interleukin-4 (IL-4), seem to have a pivotal role in the pathogenesis of juvenile idiopathic arthritis (JIA), this study is aimed at investigating of association of polymorphisms in IL-4 and IL-4 receptor α (IL-4RA) genes with susceptibility to JIA. A case-control study was conducted on 53 patients with JIA and 139 healthy unrelated controls. Single nucleotide polymorphisms of IL-4 gene at positions -1098, -590, and -33, as well as IL-4RA gene at position +1902 were genotyped using polymerase chain reaction with sequence-specific primers method and compared between patients and healthy individuals. At the allelic level, C allele at IL-4 -33 was found to be more frequent in patients compared to control (P value <0.01). At the genotypic level, CC genotype at IL-4 -590 (P value <0.01), together with CC and TT genotypes at IL-4 -33 (P value <0.01), were significantly higher in patients with JIA, while TC genotypes at IL-4 -590 and -33 positions were found to be lower in case group (P value <0.01). At the haplotypic level, IL-4 (positions -1098, -509, -33) TTC, GCC, and TTT haplotypes were significantly lower than controls (P value <0.01, P value = 0.03, and P value = 0.04, respectively). Although, TCC haplotype at the same positions was found to be higher in patients (P value <0.01). Polymorphic site of +1902 IL-4RA gene did not differ between cases and controls. Polymorphisms in promoter region of IL-4 but not IL-4RA genes confer susceptibility to JIA and may predispose individuals to adaptive immune responses.

Entities:  

Keywords:  Interleukin-4; Juvenile idiopathic arthritis; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2016        PMID: 26951255     DOI: 10.1007/s10067-016-3224-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  33 in total

1.  Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis.

Authors:  R Gerli; C Lunardi; C Pitzalis
Journal:  Rheumatology (Oxford)       Date:  2002-12       Impact factor: 7.580

2.  Cytokine single nucleotide polymorphisms in Iranian populations.

Authors:  Ali Akbar Amirzargar; Mehrnaz Naroueynejad; Farideh Khosravi; Seyed Saied Dianat; Saied Dianat; Nima Rezaei; Joannis Mytilineos; Behrouz Nikbin
Journal:  Eur Cytokine Netw       Date:  2008-06-01       Impact factor: 2.737

Review 3.  Cytokines induce the development of functionally heterogeneous T helper cell subsets.

Authors:  A O'Garra
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

4.  Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene.

Authors:  Z Song; V Casolaro; R Chen; S N Georas; D Monos; S J Ono
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

5.  Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression.

Authors:  N Arai; D Nomura; D Villaret; R DeWaal Malefijt; M Seiki; M Yoshida; S Minoshima; R Fukuyama; M Maekawa; J Kudoh
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

6.  Tumor necrosis factor-alpha single nucleotide polymorphisms in juvenile systemic lupus erythematosus.

Authors:  Fatemeh Tahghighi; Vahid Ziaee; Mohammad Hassan Moradinejad; Arezou Rezaei; Sara Harsini; Samaneh Soltani; Maryam Sadr; Maryam Mahmoudi; Yahya Aghighi; Nima Rezaei
Journal:  Hum Immunol       Date:  2015-06-24       Impact factor: 2.850

7.  Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation.

Authors:  B Li; C Tournier; R J Davis; R A Flavell
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

8.  A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage.

Authors:  Susan D Thompson; Marta B Moroldo; Laura Guyer; Mary Ryan; Esther M Tombragel; Edith S Shear; Sampath Prahalad; Marc Sudman; Mehdi A Keddache; W Mark Brown; Edward H Giannini; Carl D Langefeld; Stephen S Rich; William C Nichols; David N Glass
Journal:  Arthritis Rheum       Date:  2004-09

9.  Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset.

Authors:  L T Costallat; A M Coimbra
Journal:  Clin Exp Rheumatol       Date:  1994 Nov-Dec       Impact factor: 4.473

Review 10.  Transforming growth factor-beta regulation of immune responses.

Authors:  Ming O Li; Yisong Y Wan; Shomyseh Sanjabi; Anna-Karin L Robertson; Richard A Flavell
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

View more
  4 in total

1.  Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis.

Authors:  Vahid Ziaee; Marzieh Maddah; Mohammad-Hassan Moradinejad; Arezou Rezaei; Samaneh Zoghi; Maryam Sadr; Sara Harsini; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2016-09-20       Impact factor: 2.980

2.  Single nucleotide polymorphism of Methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis.

Authors:  Mahdi Mahmoudi; Elham Hamzeh; Saeed Aslani; Vahid Ziaee; Shiva Poursani; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2017-12-29       Impact factor: 2.980

3.  Interleukin-10 and Transforming Growth Factor Beta1 Gene Polymorphisms in Chronic Heart Failure.

Authors:  Mohammad Jafar Mahmoudi; Mona Hedayat; Mohammad Taghvaei; Sara Harsini; Ebrahim Nematipour; Nima Rezaei; Elham Farhadi; Maryam Mahmoudi; Maryam Sadr; Nilufar Esfahanian; Keramat Nourijelyani; Ali Akbar Amirzargar
Journal:  Acta Biomed       Date:  2019-05-23

4.  Are There Any Common Genetic Risk Markers for Rheumatoid Arthritis and Periodontal Diseases? A Case-Control Study.

Authors:  Susanne Schulz; Natalie Pütz; Elisa Jurianz; Hans-Günter Schaller; Stefan Reichert
Journal:  Mediators Inflamm       Date:  2019-02-12       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.